1. Hypercholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461;Salisbury;Atherosclerosis,1995
2. SCH 48461, a novel inhibitor of cholesterol absorption;Sybertz,1995
3. In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461;Van Heek;J Pharmacol Exp Ther,1987
4. Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235): A designed, potent, orally active inhibitor of cholesterol absorption;Rosenblum;J Med Chem,1998
5. Reduction of LDL-cholesterol and elevation of HDL-cholesterol in subjects with primary hypercholesterolemia by ezetimibe (SCH 58235): Pooled analysis of two phase II studies;Lipka;J Am Coll Cardiol,2000